Inventor

FEINSTEIN ELENA

IL78 patents

⚠️ This page may combine multiple inventors who share the name “FEINSTEIN ELENA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FEINSTEIN ELENA

QUARK PHARMACEUTICALS INC

Therapeutic uses of inhibitors of RTP801L

Therapeutic uses of inhibitors of RTP801

Double-stranded oligonucleotide molecules to P53 and methods of use thereof

Prevention and treatment of acute renal failure and other kidney diseases by inhibition of p53 by siRNA

Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes

Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer

Methods of treatment of acute renal failure

Methods for treating eye disorders

Therapeutic uses of inhibitors of RTP801L

Inhibitors of RTP801 and their use in disease treatment

Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases

Methods of treating ischemia-reperfusion injury with siRNAs

Methods for treating eye disorders

Tandem siRNAS

RTP801L siRNA compounds and methods of use thereof

Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof

Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof

Sequences characteristic of hypoxia-regulated gene transcription

FEINSTEIN ELENA

Compositions and methods for reducing or protecting against delayed graft function (DGF)

Therapeutic uses of inhibitors of RTP801

Double-stranded RNA directed to CASP2 and methods of use thereof

Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases

Therapeutic uses of inhibitors of RTP801

Oligoribonucleotide inhibitors of Nrf2 and methods of use thereof for treatment of cancer

Therapeutic uses of inhibitors of RTP801

Methods and compositions for treating diseases, disorders or injury of the CNS

Therapeutic uses of inhibitors of RTP801L

Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases

Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes

siRNA compounds for inhibiting NRF2

Therapeutic uses of inhibitors of RTP801

Methods of treating eye diseases in diabetic patients

NITTO DENKO CORP

Modulation of HSP47 expression

Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier

Retinoid-lipid drug carrier

Modulation of HSP47 expression

Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier

QUARK BIOTECH INC

Methods of diagnosing bladder cancer

Genes associated with mechanical stress, expression products therefrom, and uses thereof

Sequences characteristic of hypoxia-regulated gene transcription

NIITSU YOSHIRO

Retinoid-liposomes for treating fibrosis

Retinoid-liposomes for enhancing modulation of HSP47 expression

CLEVELAND BIOLABS INC

Methods and compositions for the treatment of radiation-related disorders

Methods and compositions for the treatment of radiation-related disorders

(unassigned)

Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells

INSIGHT STRATEGY & MARKETING

Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells

JIN XIAOMEI

Modulation of HSP47 expression

HADASIT MED RES SERVICE

Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells

INSIGHT BIOPHARMACEUTICALS LTD

Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells

AVKIN-NACHUM SHARON

Oligonucleotide compounds comprising non-nucleotide overhangs